In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1839 News Items found
In the Lab
MSK’s Expanded Genomics Program Takes a Deep Dive Into the Causes of Childhood Cancer

MSK molecular geneticist and data scientist Elli Papaemmanuil is leading an initiative to identify the genomic changes that drive pediatric tumors.
In the Clinic
Surgeon Mario Leitao in the operating room
For MSK’s Gynecologic Oncologists, Uncommon Cancers Aren’t Always Rare

Learn about MSK’s expertise in treating vulvar and vaginal cancers, uterine sarcoma, uncommon ovarian cancers, and gestational trophoblastic disease.
Feature
Jonathan and his nurse practitioner Joe
Inside MSK Kids: Jonathan’s Journal

Tag along with Jonathan during his most recent visit to MSK Kids. Jonathan was treated for leukemia at MSK Kids starting when he was 9.
In the Clinic
Scientific Image
New Imaging Method Could Guide Prostate Cancer Treatment

A powerful form of MRI could show whether prostate cancer is likely to grow or spread.
Q&A
Michel Talagrand, Maria Jasin, Carrie Lam Cheng Yuet-ngor, and Edward Stone
Meet Maria Jasin, an Award-Winning Biologist Who Studies DNA Repair

Maria Jasin, a member of the Sloan Kettering Institute’s Developmental Biology Program, discusses her research.
In the Clinic
MSK Leads the Way in Neurofibromatosis Research and Treatment

Learn some of the ways MSK is advancing care for people with neurofibromatosis.
Q&A
Pediatric oncologist Julia Glade Bender
Meet Julia Glade Bender, Who’s Focused on Developing Better Treatments for Kids with Cancer

Pediatric oncologist Julia Glade Bender talks about the challenges of treating rare childhood cancers and how personalized medicine is leading to better therapies for tumors that are especially hard to treat.
Feature
A woman meets with her therapist.
5 Misconceptions about Going to Therapy

Find out what going to therapy is actually like from MSK postdoctoral fellow Kailey Roberts.
In the Lab
illustration of the p53 protein binding to a DNA helix
New Findings Clarify How the “Guardian of the Genome” Works

Surprise! It has to do with metabolism.
ASTRO News: Adding Immunotherapy to Chemoradiation Decreases Local and Distant Recurrence of NSCLC

A new analysis of survival data for the randomized, phase III PACIFIC trial finds adding the immunotherapy cancer drug durvalumab to radiation and chemotherapy significantly decreased the recurrence of lung cancer both in the chest area and in distant sites outside the chest. The updated PACIFIC trial data will be presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), by Andreas Rimner, MD, radiation oncologist, Memorial Sloan Kettering Cancer Center.